ArticleCancer immunology, immunotherapy : CII2021

Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms.

Alexander W MacFarlane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.